Nova Leah
Cybersecurity compliance solution for medical device manufacturers and healthcare providers.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
€3.7m | Secondary | ||
| Total Funding | 000k | ||
| EUR | 2020 | 2021 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
More about Nova Leah
EditMade with AI
Nova Leah is a world leader in the provision of cybersecurity risk management solutions for medical device manufacturers and healthcare providers.
With SelectEvidence™, Nova Leah provides medical device manufacturers with an intelligent, automated and traceable approach to cybersecurity risk management.
Now, with SelectEvaluateⓇ, Nova Leah is transforming medical device third party risk management and cybersecurity monitoring across the healthcare cybersecurity supply chain. SelectEvaluateⓇ is launching in October 2023.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.